Fellow Eye Effect with Ranibizumab for Age Related Macular Degeneratio
Not Applicable
- Conditions
- Age Related Macular Degeneration (wet type, characterised by choroidal neovascularisation)Eye - Diseases / disorders of the eye
- Registration Number
- ACTRN12607000575437
- Lead Sponsor
- Monash University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
• ARMD with choroidal neovascularisation in both eyes
• Involvement of the foveal centre
• Age 50 years or more
• Visual Acuity (best corrected) of 6/12 or worse in both eyes (equivalent to >0.3 logMAR)
Exclusion Criteria
• Lesion size greater than 12 optic disc areas
• Previous anti Vascular Endothelial Growth Factor (anti-VEGF) therapy
• Contraindication for ranibizumab treatment
oHypersensitivity to ranibizumab
oActive or suspected ocular/periocular infection
oActive intraocular inflammation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method